Trial
NCT00807755
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Davis
Collaborators
Novartis
Condition
Lung Cancer
Intervention
Carboplatin
Why stopped
Number of known toxicities observed despite a treatment-naïve population
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-09